-
Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study
Sep 9, 2025, 16:22 PM -
Costs and Their Impacts That Should Be Included in Health Technology Assessment of Remote Palliative Care
Sep 9, 2025, 16:22 PM -
Shifts in the French HTA Transparency Committee’s Use of Indirect Comparisons: Insights From a Systematic Review of the French Transparency Committee (TC) Opinions
Sep 9, 2025, 16:22 PM -
Navigating HTA and Innovation: Oncologists’ Perspectives on Access to Cancer Therapies in Bulgaria
Sep 9, 2025, 16:22 PM -
The Alignment Between Technology Incorporations and Actual Health Needs
Sep 9, 2025, 16:22 PM -
Using Directed Acyclic Graphs in Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison: Systematic Review and Methodological Insights
Sep 9, 2025, 16:22 PM -
Direct and Indirect Economic Burden Due to Chronic Limb-Threatening Ischemia (CLTI) in Germany
Sep 9, 2025, 16:22 PM -
Reimbursement Trends for Advanced Therapeutic Medicinal Products (ATMPs) in Europe
Sep 9, 2025, 16:22 PM -
Negotiated Closed Budgets in Greece: A Case Study of Success in Enhancing Patient Access Whilst Achieving Savings
Sep 9, 2025, 16:22 PM -
Disease Management in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Belatacept as Conversion Therapy in the Management of Patients Living With a Renal Graft in France
Sep 9, 2025, 16:22 PM -
Socioeconomic Disparities in Access to Treatment for Major Depressive Disorder: The Role of Accumulator and Maximizer Insurance Plans
Sep 9, 2025, 16:22 PM -
Publicly Funded Fertility Preservation Services for Medical Reasons in Selected Countries
Sep 9, 2025, 16:22 PM -
An Integrated Web-Based Approach to Survival Analysis and Extrapolation for Economic Modeling
Sep 9, 2025, 16:22 PM -
Direct Economic Impact of Idiopathic Pulmonary Fibrosis on the Brazilian Private Healthcare System: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Positioning of the Eluvia™, Drug-Eluting Stent in the Treatment of Peripheral Artery Disease (PAD) in Türkiye: Insights From a Specialist Panel Survey and Focus Group Study
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL for Vasomotor Symptoms Caused by Endocrine Therapy: Reliability, Validity, and Differential Item Functioning
Sep 9, 2025, 16:22 PM -
Grounded Theory Study to Assess Barriers and Reasons for Insufficient Compliance With Valproate Risk Minimization Measures: Example of a Qualitative Method Aligned With the Recommendations of the GVP Module XVI, Addendum II
Sep 9, 2025, 16:22 PM -
The 90-Day Ambition: Historical Analysis of 200 NICE Appraisals to Assess Proportion-Achieving Final Guidance Within 90 Days of MHRA Approval
Sep 9, 2025, 16:22 PM -
UDCA Treatment Response in Primary Biliary Cholangitis in the United States
Sep 9, 2025, 16:22 PM